Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Short-Term Debt issuances (2023 - 2025)

BrightSpring Health Services' Short-Term Debt issuances history spans 3 years, with the latest figure at -$63.3 million for Q1 2025.

  • For Q1 2025, Short-Term Debt issuances fell 24.85% year-over-year to -$63.3 million; the TTM value through Dec 2025 reached -$63.3 million, down 602.38%, while the annual FY2025 figure was -$63.3 million, 602.38% down from the prior year.
  • Short-Term Debt issuances reached -$63.3 million in Q1 2025 per BTSG's latest filing, down from -$33.8 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $55.8 million in Q2 2024 to a low of -$122.4 million in Q4 2023.
  • Average Short-Term Debt issuances over 3 years is -$20.2 million, with a median of -$33.8 million recorded in 2024.
  • Peak YoY movement for Short-Term Debt issuances: soared 72.37% in 2024, then decreased 24.85% in 2025.
  • A 3-year view of Short-Term Debt issuances shows it stood at -$122.4 million in 2023, then skyrocketed by 72.37% to -$33.8 million in 2024, then crashed by 87.28% to -$63.3 million in 2025.
  • Per Business Quant, the three most recent readings for BTSG's Short-Term Debt issuances are -$63.3 million (Q1 2025), -$33.8 million (Q4 2024), and $41.3 million (Q3 2024).